Concepedia

Xiaobo Li

XL

Statistics

Publications

8

Citations

380

H-Index

8

Active since

2013

Affiliations

Tianjin Medical University(Current)

Children's Healthcare of Atlanta

Emory University

Tianjin Institute of Pharmaceutical Research (China)

Anhui Medical University

Xiaobo Li is an author at Tianjin Medical University specializing in medicine, tumor biology, and drug discovery.

ORCID

Top concepts

Publications per year

2013–2023

8

Publications

8

MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling

Ke Xu, Guo Chen, Xiaobo Li et al. · Scientific Reports · 2017 · 157 citations · Full text

Small Molecule Inhibitor that Stabilizes the Autoinhibited Conformation of the Oncogenic Tyrosine Phosphatase SHP2

Xiaoqin Wu, Gang Xu, Xiaobo Li et al. · Journal of Medicinal Chemistry · 2018 · 49 citations · Full text

Gain-of-function mutations of <i>Ptpn11</i> (Shp2) cause aberrant mitosis and increase susceptibility to DNA damage-induced malignancies

Xia Liu, Hong Zheng, Xiaobo Li et al. · Proceedings of the National Academy of Sciences · 2016 · 47 citations · Full text

Oncogenic Smurf1 promotes PTEN wild-type glioblastoma growth by mediating PTEN ubiquitylation

Xia Qin, Hanwen Zhang, Pei Zhang et al. · Oncogene · 2020 · 43 citations

, , +8

Structure based design, synthesis and activity studies of small hybrid molecules as HDAC and G9a dual inhibitors

Lanlan Zang, Shukkoor Muhammed Kondengaden, Qing Zhang et al. · Oncotarget · 2017 · 35 citations · Full text

, , +26

1–5 of 8